Navigation Links
New genital gel could empower women against the AIDS epidemic

John Moore of Cornell University in New York and his colleagues are enthused by their finding of a new viral blocker that prevents the virus from burying into human cells. This blocker, in its initial testing in monkeys was found to curb sexual transmission of HIV between monkeys. The new study has backed the belief that microbicides - chemicals that hobble viruses - could act as shields against HIV. This or other microbicides, applied in cream form to the vagina or rectum could// save the lives of several women who are not able to protect themselves by monogamy or by using condoms.

Researchers are investigating around 60 potential microbicides that thwart HIV in a variety of ways. Carraguard, a microbicide extracted from seaweeds is already into phase III clinical trials in Southern Africa. Carraguard gums up the surface of virus and vaginal cells to create a physical barrier against infection. Other products being tested, such as Buffergel, instead increase acidity to oust the virus. However, some of the other candidates in this category like the spermicide nonoxynol-9 have been found to increase HIV infection as attack and weaken vaginal cell walls, as well as the target virus.

In the new study, researchers used a human antibody called b12 that binds an HIV coat protein and stops it latching onto cells. They found that when this product was used in monkeys two hours before sex, it prevented infection in 9 out of 12 monkeys, while 12 out of 13 monkeys were infected without the antibody. This antibody, unlike certain other microbicides targets only the HIV virus and does not affect healthy cells.


'"/>




Page: 1

Related medicine news :

1. Kids with Congenital Heart Disease Found To Have Low I.Q Levels
2. Infection in pregnancy can lead to congenital eye defects
3. Enzyme Responsible For Congenital Blindness
4. Exercise to childrens with congenital disease beneficial
5. Fungal toxins infected corn the reason for congenital defects
6. Anti-Parasitic Drugs Useful in Reducing Damages of Congenital Toxoplasmosis
7. Gene Therapy May Help Restore Sight In Congenital blindness
8. NSAIDs In First trimester Linked To Congenital Anomalies In Babies
9. Competitive women cyclists experience reduced genital sensation
10. Babies With Congenital Heart Defects Live Longer, Study Shows
11. Virus Level could Predict Cervical Cancer Risk
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/27/2016)... Overland Park, KS (PRWEB) , ... June 27, 2016 , ... ... leader in retailers of Eyeglasses . , Millions of individuals in the United ... life, eyeglasses have become a way to both correct vision and make a fashion ...
(Date:6/26/2016)... , ... June 26, 2016 , ... PawPaws brand ... new product that was developed to enhance the health of felines. The formula is ... The two main herbs in the PawPaws Cat Kidney Support Supplement Soft ...
(Date:6/25/2016)... ... , ... Austin residents seeking Mohs surgery services, can now turn to Dr. ... Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to include ... in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn ...
(Date:6/25/2016)... , ... June 25, 2016 , ... As a lifelong ... Cum Laude and his M.D from the David Geffen School of Medicine at UCLA. ... to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... A recent ... that most people are unfamiliar with. The article goes on to state that individuals ... also many of these less common operations such as calf and cheek reduction. The ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... June 23, 2016 Research and ... Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), ... Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is projected ... CAGR of 6.1% in the forecast period 2016 to ...
(Date:6/23/2016)... 23, 2016 Roche (SIX: RO, ROG; OTCQX: ... its Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated ... shock. With this clearance, Roche is the first IVD ... solution for sepsis risk assessment and management. ... and PCT levels in blood can aid clinicians in ...
(Date:6/23/2016)... ANGELES , June 23, 2016 ... CAPR ), a biotechnology company focused ... therapeutics, today announced that patient enrollment in its ... in Duchenne) has exceeded 50% of its 24-patient ... enrollment in the third quarter of 2016, and ...
Breaking Medicine Technology: